Short interest in AN2 Therapeutics Inc (NASDAQ:ANTX) increased during the last reporting period, rising from 74.08K to 90.03K. This put 0.47% of the company's publicly available shares short.

Short interest for AN2 Therapeutics gives investors a sense of the degree to which investors are betting on the decline of AN2 Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 184.83K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.